An innovative NIMH-funded trial shows that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders.
Source: NIH
Science News » Fast-Fail Trial Shows New Approach to Identifying Brain Targets for Clinical Treatments
Published in Psychiatric
More from PsychiatricMore posts in Psychiatric »
- Mental health app review site: Applying the CRAAP test
- Scientific Meeting » NIMH Livestream Event: Suicide Prevention Strategies
- Scientific Meeting » Virtual Workshop: Genes to Biology: Integrative Systematic Approaches for Revealing Biological Functions of Psychiatric Risk Genes and Alleles
- Blog Post » Addressing the Crisis of Black Youth Suicide
Be First to Comment